RNA Stool Test Shows High Sensitivity for CRC Detection
A multi-target stool RNA test effectively screened individuals age 45 and older for colorectal cancer and advanced adenomas.
Source: hcplive.com
Multi Target Stool News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Multi Target Stool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Multi Target Stool Today - Breaking & Trending Today
FinancialNewsMedia.com: Groundbreaking Clinical Trials Accelerating New Treatment Options for Pancreatic Cancer
PALM BEACH, Fla., Feb. 2, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - In the battle against pancreatic cancer, new and innovative clinical trials have become extremely critical.
Source: finanznachrichten.de
Exact Sciences Presents Data Showing Improved Accuracy of Second-generation Cologuard® Test and Progress Toward an Even Better Colorectal Cancer Screening Solution for Patients
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced performance data for a second-generation Cologuard (multi-target stool DNA) test showing...
Source: prnewswire.com
Exact Sciences Presents Data Showing Improved Accuracy of Second-generation Cologuard® Test and Progress Toward an Even Better Colorectal Cancer Screening Solution for Patients
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced performance data for a second-generation Cologuard (multi-target stool DNA) test showing...
Source: prnewswire.com
Exact Sciences Applauds Final Task Force Recommendation That Lowers Starting Age for Colorectal Cancer Screening to 45
Exact Sciences Applauds Final Task Force Recommendation That Lowers Starting Age for Colorectal Cancer Screening to 45 National Task Force supports Cologuard® as a screening option and screening expands to an additional ˜19 million Americans News provided by Share this article Share this article MADISON, Wis., May 18, 2021 /PRNewswire/ -- The United States Preventive Services Task Force (USPSTF) today released its final colorectal cancer screening recommendation that screening begin at age 45. Exact Sciences' (NASDAQ: EXAS) Cologuard ®, referred to as sDNA-FIT, is included as a recommended...
Source: prnewswire.com